NICE denies multiple sclerosis star Ocrevus on price, thwarting Roche yet again

5th April 2018 Uncategorised 0

Crowding in the multiple sclerosis field hasn’t stopped new Roche drug Ocrevus from making a splash. But that competition is making it tough for the Swiss drugmaker to snag reimbursement in England.

More: NICE denies multiple sclerosis star Ocrevus on price, thwarting Roche yet again
Source: fierce